New hope in the treatment of painful symptoms in depression

Current Opinion in Investigational Drugs

Volumn 4, Issue 1, 2003, Pages 42-45

  Briley, Mike ^a  

^a NeuroBiz Consulting and Communication   (France)

Author keywords

Duloxetine; Milnacipran; Norepinephrine; Pain; Serotonin; Venlafaxine

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MILNACIPRAN; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THIONISOXETINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE; ZIMELDINE;

ANTINOCICEPTION; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG TOXICITY; DRUG WITHDRAWAL; HUMAN; MENTAL DISEASE; META ANALYSIS; MOOD; NONHUMAN; NORADRENALIN UPTAKE; OPEN STUDY; PHYSICAL DISEASE; PRIMARY MEDICAL CARE; PSYCHOPHARMACOLOGY; PSYCHOSOMATIC DISORDER; REMISSION; REVIEW; SEROTONIN UPTAKE;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; CYCLOHEXANOLS; CYCLOPROPANES; DEPRESSIVE DISORDER; HUMANS; PAIN; THIOPHENES;

EID: 0037284434     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Stahl SM: Does depression hurt? J Clin Psychiatry (2002) 63(4):273-274. A thougth-provoking article in non-technical language aimed at the prescribing physician.
2. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ: Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry (1993) 150(5):734-741.
3. Corruble E, Guelfi JD: Pain complaints in depressed inpatients. Psychopathology (2000) 33(6):307-309.
4. Gerber PD, Barrett JE, Barrett JA, Oxman TE, Manheimer E, Smith R, Whiting RD: The relationship of presenting physical complaints to depressive symptoms in primary care patients. J Gen Intern Med (1992) 7(2):170-173.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. American Psychiatric Association, Washington, DC, USA (1994).
6. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 6(4):278-296.
7. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 134:382-389.
8. Dohrenwend BP, Raphael KG, Marbach JJ, Gallagher RM: Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses. Pain (1999) 83(2):183-192.
9. Banks SM, Kerns RD: Explaining high rates of depression in chronic pain: A diathesis-stress framework. Psychological Bulletin (1996) 119:95-110. A complete examination of the relationship between pain and depression.
10. Gureje O, Simon GE, Von Korff M: A cross-national study of the course of persistent pain in primary care. Pain (2001) 92(1-2):195-200.
11. Van Korff M, Simon G: The relationship between pain and depression. Br J Psychiatry Suppl (1996) (30):101-108. Another thorough discussion of the relationship between pain and depression.
12. Kranzler JD, Gendreau JF, Rao SG: The psychopharmacology of fibromyalgia: A drug development perspective. Psychopharmacol Bull (2002) 36(1):165-213. A recent, very comphrensive review of FMS.
13. Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr: Fibromyalgia and major affective disorder: A controlled phenomenology and family history study. Am J Psychiatry (1985) 142(4):441-446.
14. Briley M: The logical evolution toward dual action antidepressants. Drugs Focus (2001) 3(Suppl 1):5-10.
15. Sierralta F, Pinardi G, Miranda HF: Effect of p-chlorophenylalanine and α-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol Toxicol (1995) 77(4):276-280.
16. Wall PD, Melzack R (Eds): Textbook of Pain, 4th Edition. Churchill Livingston, New York, NY, USA (1999).
17. Esser MJ, Sawynok J: Acute amitriptyline in a rat model of neuropathic pain: Differential symptom and route effects. Pain (1999) 80(3):643-653.
18. Sawynok J, Esser MJ, Reid AR: Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain (1999) 82(2):149-158.
19. Stahl SM: The psychopharmacology of painful physical symptoms in depression. J Clin Psychiatry (2002) 63(5):382-383.
20. Tura B, Tura SM: The analgesic effect of tricyclic antidepressants. Brain Res (1990) 518(1-2):19-22.
21. Rao SG, King TE, Porreca F: Analgesic efficacy of repeated milnacipran in persistent pain. American College of Rheumatology Annual Scientific Meeting (2002):Abs 191.
22. Yokogawa F, Kiuchi Y, Ishikawa Y, Otsuka N, Masuda Y, Oguchi K, Hosoyamada A: An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth Analg (2002) 95(1):163-168.
23. O'Malley PG, Jackson JL, Santoro J, Tomkins G, Balden E, Kroenke K: Antidepressant therapy for unexplained symptoms and symptom syndromes. J Family Pract (1999) 48(12):980-990.
24. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL: Treatment of fibromyalgia with antidepressants: A meta-analysis. J Gen Intern Med (2000) 15(9):659-666. A global of the efficacy of antidepressants in fibromyalgia.
25. Max MB: Treatment of post-herpetic neuralgia: Antidepressants. Ann Neurol (1994) 35(Suppl):S50-S53.
26. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Evidence-based data from animal and human experimental studies on pain relief with antidepressants: A structured review. Pain Medicine (2000) 1:310-316. A major review of the animal and clinical data for the efficacy of antidepressants in the treatment of pain.
27. Enggaard TP, Klitgaard NA, Gram LF, Arendt-Nielsen L, Sindrup SH: Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther (2001) 69(4):245-251.
28. Taylor K, Rowbotham MC: Venlafaxine hydrochloride and chronic pain. West J Med (1996) 165(3):147-148.
29. Davis JL, Smith RL: Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care (1999) 22(11):1909-1910.
30. Lithner F: Venlafaxine in treatment of severe painful peripheral diabetic neuropathy. Diabetes Care (2000) 23(11):1710-1711.
31. Kunz NR, Goli V, Entsuah R, Rudolph R: Diabetic neuropathic pain management with venlafaxine extended release. Eur Neuropsychopharmacol (2000) 10(Suppl 3):389.
32. Kiayias JA, Vlachou ED, Lakka-Papadodima E: Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy. Diabetes Care (2000) 23(5):699.
33. Dwight MM, Arnold LM, O'Brien H, Metzger R, Morris-Park E, Keck PE Jr: An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics (1998) 39(1):14-17.
34. Sumpton JE, Moulin DE: Treatment of neuropathic pain with venlafaxine. Ann Pharmacother (2001) 35(5):557-559.
35. Tasmuth T, Hartel B, Kalso E: Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain (2002) 6(1):17-24.
36. Toyofuku A: Efficacy of milnacipran for glossodynia patients. Int J Psychiatry Clin Practice (2002) 6:256.
37. Tanikawa H: Efficacy of milnacipran in patients with chronic orthopaedic pain including degenerative spondylosis and osteoarthritis. Int J Psychiatry Clin Practice (2002) 6:255.
38. Utsunomiya K, Ukita T, Hirota S: A case of postherpetic neuralgia treated with milnacipran. Jpn J Clin Psychopharmacol (2002) 5:193-196.
39. Simamoto E, Doi N, Suwa H, Shibui F, Ishimaru K, Fukubayashi N: A case of postherpetic neuralgia improved by milnacipran. Jpn J Clin Psychopharmacol (2002) 5:197-200.
40. Milnacipran significantly improves pain and fatigue in fibromyalgia patients. Cypress Bioscience Inc, Press Release (2002).
41. Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA: Duloxetine, 60 mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial. J Clin Psychiatry (2002) 63(4):308-315. First publication indicating the efficacy of duloxetine in pain as well as in depression.
42. Thase ME, Entsuah AR, Rudolph RL: Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry (2001) 178(3):234-241.